close icon-linkedin icon-twitter icon-facebook icon-mail icon-google-plus icon-search icon-phone icon-instagram
What are you looking for?
white paper immunotherapy
news 18 May 2017

BioVox White Paper on Cancer Immunotherapy

Our partner BioVox published a White Paper on 'Cancer Immunotherapy'. NLO's Caroline Pallard joined the expert panel and discussed the IP issues. Download the White Paper for free.

The BioVox White Paper on Cancer Immunotherapy showcases innovators and world leaders in this exciting field, including GSK Biologicals, Janssen Immunosciences, Celyad, RXi Pharmaceuticals, eTheRNA, ImmunXperts, iTeos Therapeutics and PDC*line Pharma.

In this issue:

  • Why is immunotherapy more than the latest hype?
  • What are the challenges to bring lifesaving innovations to the patient
  • The price of life: who will pay for these treatments?
  • Pioneering immunotherapy companies in the picture
  • Insight in landmark oncology trials
  • Academic innovations in immunotherapy

You may download the White Paper here:

White paper 'Immunotherapy: a cure for cancer?'
pdf - 3.18 MB